Literature DB >> 11571771

Psychotropic drug use in elderly people with and without dementia.

M S Giron1, Y Forsell, C Bernsten, M Thorslund, B Winblad, J Fastbom.   

Abstract

OBJECTIVE: To determine the prevalence of psychotropic drug use in very old persons with and without dementia in two time periods, and describe the patterns of psychotropic drug use between institutions and non-institutions.
METHODS: Descriptive analysis on a sample of subjects aged 81+ from a population-based study in Stockholm, Sweden. Psychotropic drug use data were collected from the 1987-1989 and 1994-1996 periods of the study. The diagnosis of dementia was based on the DSM III-R.
RESULTS: About 41% of the subjects used at least one psychotropic drug in both periods. Women and subjects in institutions more commonly used psychotropic drugs. The most commonly reported were, in rank order, hypnotics-sedatives, anxiolytics, antipsychotics and antidepressants. Hypnotics-sedatives and anxiolytics were the most commonly used in both institutions and non-institutions. More persons with dementia used psychotropic drugs in both periods. The use of newer drugs, for example, SSRI, was evident. Multivariate analyses showed increased risk for psychotropic drug use among subjects in institutions.
CONCLUSIONS: This study confirms the high rate of psychotropic drug use in the very old, particularly in persons with dementia. Psychotropic drug use was high among subjects living in institutions. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571771     DOI: 10.1002/gps.438

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  26 in total

1.  Use of psychotropics is high among very old people.

Authors:  Sirpa Hartikainen; Timo Klaukka
Journal:  Eur J Clin Pharmacol       Date:  2003-12-02       Impact factor: 2.953

2.  Antidepressant Use in the Elderly Is Associated With an Increased Risk of Dementia.

Authors:  Chenkun Wang; Sujuan Gao; Hugh C Hendrie; Joe Kesterson; Noll L Campbell; Anantha Shekhar; Christopher M Callahan
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

3.  Pain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly.

Authors:  Ylva Haasum; Johan Fastbom; Laura Fratiglioni; Ingemar Kåreholt; Kristina Johnell
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

4.  Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland.

Authors:  Helka Hosia-Randell; Kaisu Pitkälä
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Psychotropic medication use for behavioral symptoms of dementia.

Authors:  Philip S Wang; M Alan Brookhart; Soko Setoguchi; Amanda R Patrick; Sebastian Schneeweiss
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

6.  Evaluation of the quality of drug therapy among elderly patients in nursing homes.

Authors:  Asa Bergman; Jonny Olsson; Anders Carlsten; Margda Waern; Johan Fastbom
Journal:  Scand J Prim Health Care       Date:  2007-03       Impact factor: 2.581

7.  To what extent does the indicator "concurrent use of three or more psychotropic drugs" capture use of potentially inappropriate psychotropics among the elderly?

Authors:  Eva Lesén; Max Petzold; Karolina Andersson; Anders Carlsten
Journal:  Eur J Clin Pharmacol       Date:  2009-02-12       Impact factor: 2.953

8.  Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Drugs Aging       Date:  2012-09       Impact factor: 3.923

9.  Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.

Authors:  Krista F Huybrechts; Kenneth J Rothman; Rebecca A Silliman; M Alan Brookhart; Sebastian Schneeweiss
Journal:  CMAJ       Date:  2011-03-28       Impact factor: 8.262

10.  Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data.

Authors:  Sebastian Schneeweiss; Soko Setoguchi; M Alan Brookhart; Liljana Kaci; Philip S Wang
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.